AKR1B10 and non-small cell lung carcinoma: Using a multi-organ microfluidic bionic chip platform, Liu et al. [93] convincingly showed a significant upregulation of AKR1B10 in bone metastasis of NSCLC verifying its efficacy as a valuable serum biomarker of bone metastasis.